INTESTINAL FAILURE ASSOCIATED LIVER DISEASE IN ADULT PATIENTS: A ONE-YEAR PROSPECTIVE STUDY

Nutrition ◽  
2019 ◽  
Vol 65 ◽  
pp. 2
Author(s):  
A.S. Sasdelli ◽  
M. Guidetti ◽  
C. Pazzeschi ◽  
L. Pironi
Keyword(s):  
Liver Disease ◽  
Prospective Study ◽  
Intestinal Failure ◽  
Adult Patients ◽  
One Year

Intestinal failure associated liver disease: A one-year prospective study

2020 ◽  
Vol 40 ◽  
pp. 514
Author(s):  
A.S. Sasdelli ◽  
M. Guidetti ◽  
C. Pazzeschi ◽  
A. Musio ◽  
G.A. Mari ◽  
...  
Keyword(s):  
Liver Disease ◽  
Prospective Study ◽  
Intestinal Failure ◽  
One Year

TREATMENT OF TRIGGER FINGERS BY INJECTION OF METHYLPREDNISOLONE ACETATE AND LIDOCAINE (DEPO-MEDROL®)

Hand Surgery ◽  
1996 ◽  
Vol 01 (02) ◽  
pp. 103-105
Author(s):  
J. Joris Hage ◽  
Jaap D.K. Munting
Keyword(s):  
Side Effects ◽  
Prospective Study ◽  
Success Rate ◽  
Adult Patients ◽  
Methylprednisolone Acetate ◽  
Short Term ◽  
Local Injections ◽  
One Year ◽  
A Prospective Study

Thirty-six adult patients with 44 trigger fingers of less than four months' duration entered a prospective study on the efficiency of treatment with local injections of a combination of corticosteroids and lidocaine. From this study it may be concluded that the short-term success rate (93%) of one to three injections of methylprednisolone and lidocaine 2% (Depo-Medrol®) is comparable to that achieved by surgical or percutaneous tenolysis. At one year of follow-up, this success rate still amounted to 86%. In our hands, this therapy is without complications or side effects.

A Prospective Study of Prevalence, Risk Factors, and Severity of Intestinal Failure-Associated Liver Disease

2016 ◽  
Vol 64 (2) ◽  
pp. S739 ◽  
Author(s):  
S.H. Skadegaard ◽  
A. Krag ◽  
P.B. Jeppesen ◽  
M.J. Nielsen ◽  
M. Karsdal ◽  
...  
Keyword(s):  
Risk Factors ◽  
Liver Disease ◽  
Prospective Study ◽  
Intestinal Failure ◽  
A Prospective Study

scholarly journals Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients.

Thorax ◽  
1996 ◽  
Vol 51 (2) ◽  
pp. 179-184 ◽  
Author(s):  
D. Lieberman ◽  
F. Schlaeffer ◽  
I. Boldur ◽  
D. Lieberman ◽  
S. Horowitz ◽  
...  
Keyword(s):  
Prospective Study ◽  
Community Acquired Pneumonia ◽  
Adult Patients ◽  
One Year ◽  
Multiple Pathogens

Effects of Probiotics on Intestinal Failure–Associated Liver Disease in Adult Patients Receiving Prolonged Parenteral Support: A Tertiary Care Center Experience

2019 ◽  
Vol 35 (3) ◽  
pp. 454-463
Author(s):  
Mohammad Alomari ◽  
Leen Nusairat ◽  
Laith Al Momani ◽  
Pravallika Chadalavada ◽  
Fahrettin Covut ◽  
...  
Keyword(s):  
Liver Disease ◽  
Care Center ◽  
Tertiary Care ◽  
Intestinal Failure ◽  
Adult Patients ◽  
Tertiary Care Center ◽  
Parenteral Support

scholarly journals Intravenous Lipid Emulsions in the Prevention and Treatment of Liver Disease in Intestinal Failure

Nutrients ◽  
2021 ◽  
Vol 13 (3) ◽  
pp. 895
Author(s):  
Fedja A. Rochling
Keyword(s):  
Liver Disease ◽  
Fish Oil ◽  
Biological Effects ◽  
Case Reports ◽  
Intestinal Failure ◽  
Adult Patients ◽  
Laboratory Animals ◽  
Lipid Emulsions ◽  
Prevention And Treatment

The development of intestinal failure-associated liver disease (IFALD) in pediatric and adult patients on parenteral nutrition is usually multifactorial in nature due to nutritional and non-nutritional causes. The role of lipid therapy as a contributing cause is well-established with the pathophysiological pathways now better understood. The review focuses on risk factors for IFALD development, biological effects of lipids, lipid emulsions and the mechanisms of lipid toxicity observed in laboratory animals followed by a synopsis of clinical studies in pediatric and adult patients. The introduction of fish oil-based lipid emulsions that provide partial or complete lipid replacement therapy has resulted in resolution of IFALD that had been associated with soybean oil-based therapy. Based on case reports and cohort studies in pediatric and adult patients who were at risk or developed overt liver disease, we now have more evidence that an early switch to partial or complete fish oil–based lipid therapy should be implemented in order to successfully halt and reverse IFALD.

Sign in / Sign up

Export Citation Format

Share Document